105 related articles for article (PubMed ID: 22052941)
1. Effect of single post-ovulatory administration of levonorgestrel on gene expression profile during the receptive period of the human endometrium.
Vargas MF; Tapia-Pizarro AA; Henríquez SP; Quezada M; Salvatierra AM; Noe G; Munroe DJ; Velasquez LA; Croxatto HB
J Mol Endocrinol; 2012 Feb; 48(1):25-36. PubMed ID: 22052941
[TBL] [Abstract][Full Text] [Related]
2. Effect of single post-ovulatory administration of mifepristone (RU486) on transcript profile during the receptive period in human endometrium.
Cuevas CA; Tapia-Pizarro A; Salvatierra AM; Munroe DJ; Velasquez L; Croxatto HB
Reproduction; 2016 Apr; 151(4):331-49. PubMed ID: 26755688
[TBL] [Abstract][Full Text] [Related]
3. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Endometrial Transcriptome at the Time of Implantation in Women Receiving a Single Post-Ovulatory Dose of Levonorgestrel or Mifepristone.
Barrios-Hernández AE; Durand-Carbajal M; Vega CC; Larrea F
Rev Invest Clin; 2020 Dec; 72(6):363-371. PubMed ID: 33053570
[TBL] [Abstract][Full Text] [Related]
5. Effect of low-dose mifepristone administration on day 2 after ovulation on transcript profiles in implantation-stage endometrium of rhesus monkeys.
Ghosh D; Sharkey AM; Charnock-Jones DS; Smith SK; Sengupta J
Reproduction; 2009 Aug; 138(2):357-70. PubMed ID: 19439560
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral and vaginal administration of levonorgestrel emergency contraception on markers of endometrial receptivity.
Meng CX; Marions L; Byström B; Gemzell-Danielsson K
Hum Reprod; 2010 Apr; 25(4):874-83. PubMed ID: 20139427
[TBL] [Abstract][Full Text] [Related]
7. Late follicular phase administration of levonorgestrel as an emergency contraceptive changes the secretory pattern of glycodelin in serum and endometrium during the luteal phase of the menstrual cycle.
Durand M; Seppala M; Cravioto Mdel C; Koistinen H; Koistinen R; González-Macedo J; Larrea F
Contraception; 2005 Jun; 71(6):451-7. PubMed ID: 15914136
[TBL] [Abstract][Full Text] [Related]
8. Hormonal evaluation and midcycle detection of intrauterine glycodelin in women treated with levonorgestrel as in emergency contraception.
Durand M; Koistinen R; Chirinos M; Rodríguez JL; Zambrano E; Seppälä M; Larrea F
Contraception; 2010 Dec; 82(6):526-33. PubMed ID: 21074015
[TBL] [Abstract][Full Text] [Related]
9. Effect of single administration of levonorgestrel on the menstrual cycle.
Okewole IA; Arowojolu AO; Odusoga OL; Oloyede OA; Adeleye OA; Salu J; Dada OA
Contraception; 2007 May; 75(5):372-7. PubMed ID: 17434019
[TBL] [Abstract][Full Text] [Related]
10. Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model.
Meng CX; Andersson KL; Bentin-Ley U; Gemzell-Danielsson K; Lalitkumar PG
Fertil Steril; 2009 Jan; 91(1):256-64. PubMed ID: 18206148
[TBL] [Abstract][Full Text] [Related]
11. Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model.
Lalitkumar PG; Lalitkumar S; Meng CX; Stavreus-Evers A; Hambiliki F; Bentin-Ley U; Gemzell-Danielsson K
Hum Reprod; 2007 Nov; 22(11):3031-7. PubMed ID: 17890724
[TBL] [Abstract][Full Text] [Related]
12. A single midcycle dose of levonorgestrel similar to emergency contraceptive does not alter the expression of the L-selectin ligand or molecular markers of endometrial receptivity.
Palomino WA; Kohen P; Devoto L
Fertil Steril; 2010 Oct; 94(5):1589-94. PubMed ID: 19909947
[TBL] [Abstract][Full Text] [Related]
13. Effect of mifepristone on the transcriptomic signature of endometrial receptivity.
von Grothusen C; Lalitkumar PG; Ruiz-Alonso M; Boggavarapu NR; Navarro R; Miravet-Valenciano J; Gemzell-Danielsson K; Simon C
Hum Reprod; 2018 Oct; 33(10):1889-1897. PubMed ID: 30137464
[TBL] [Abstract][Full Text] [Related]
14. Endometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placebo.
Anderson FD; Feldman R; Reape KZ
Contraception; 2008 Feb; 77(2):91-6. PubMed ID: 18226671
[TBL] [Abstract][Full Text] [Related]
15. Endometrial effects of intrauterine levonorgestrel.
Guttinger A; Critchley HO
Contraception; 2007 Jun; 75(6 Suppl):S93-8. PubMed ID: 17531624
[TBL] [Abstract][Full Text] [Related]
16. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
[TBL] [Abstract][Full Text] [Related]
17. Changes in glandular and stromal estrogen and progesterone receptor isoform expression in eutopic and ectopic endometrium following treatment with the levonorgestrel-releasing intrauterine system.
Engemise SL; Willets JM; Taylor AH; Emembolu JO; Konje JC
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):101-6. PubMed ID: 21470761
[TBL] [Abstract][Full Text] [Related]
18. Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function.
Marions L; Cekan SZ; Bygdeman M; Gemzell-Danielsson K
Contraception; 2004 May; 69(5):373-7. PubMed ID: 15105059
[TBL] [Abstract][Full Text] [Related]
19. The effect of levonorgestrel-releasing intrauterine device (20 micrograms/day) (LNG-IUD-20) on the morphological structure of human endometrium: a study of the endometrial factor VIII activity in the women before and after insertion of LNG-IUD-20 by the digital image analysis.
Zhu P; Liu X; Luo H; Gu Z; Wang J; Xu L; Cheng J; Xu R; Lian S; Cui Y
Contraception; 1995 Jul; 52(1):63-8. PubMed ID: 8521717
[TBL] [Abstract][Full Text] [Related]
20. Ulipristal acetate administration at mid-cycle changes gene expression profiling of endometrial biopsies taken during the receptive period of the human menstrual cycle.
Lira-Albarrán S; Durand M; Larrea-Schiavon MF; González L; Barrera D; Vega C; Gamboa-Domínguez A; Rangel C; Larrea F
Mol Cell Endocrinol; 2017 May; 447():1-11. PubMed ID: 28219738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
